The Boston Red Sox are holding out hope that Chris Sale's season isn't lost.
The Red Sox are awaiting Dr. Neal ElAttrache's opinion on the MRI that Sale underwent Monday on his injured elbow, manager Ron Roenicke told reporters Wednesday.
ElAttrache will be the third party to assess Sale's elbow after the Red Sox' medical staff and Dr. James Andrews reviewed his MRI.
"We need to get this right," Roenicke said, via The Boston Globe's Pete Abraham, adding that fans shouldn't assume the worst-case scenario with Sale.
But things certainly don't look good for the 30-year-old left-hander, who experienced elbow soreness Sunday while throwing live batting practice.
Sale's 2019 campaign ended in August when he received a PRP injection instead of opting for surgery. He already was set to begin the 2020 season on the Injured List after a spring training bout with pneumonia.
Sale was supposed to be the Red Sox' ace this season, but it's very possible he could miss a significant portion of the year, further depleting a rotation that lost David Price and Rick Porcello this offseason.